Updated:
Cell Innovation Partners
Cell Innovation Partners is a healthcare venture fund established by Reprocell and Shinsei Bank Group. It focuses on regenerative medicine and...
Overview
Cell Innovation Partners is a healthcare venture fund established by Reprocell and Shinsei Bank Group. It focuses on regenerative medicine and next-generation stem cell therapies. The fund has made 3 investments, including a Series B - II investment in Symic Bio on April 25, 2019.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
Asia
Country
Japan
City
Kanagawa
Corporate office
Kanagawa, Japan
Sector focus
Frequently asked questions
What is the investment focus of Cell Innovation Partners?
The firm lists a venture generalist strategy.
Where is Cell Innovation Partners headquartered?
Records place the firm in Kanagawa, Japan.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: